urapidil and digoxin
urapidil has been researched along with digoxin in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Haerlin, R; Klingmann, I; Mosberg, H; Solleder, P; Wurst, W | 1 |
| Haerlin, R; Kirsten, R; Nelson, K; Steinijans, VW; Zech, K | 1 |
Reviews
1 review(s) available for urapidil and digoxin
| Article | Year |
|---|---|
Clinical pharmacokinetics of urapidil.
Topics: Adult; Aged; Aged, 80 and over; Aging; Digoxin; Drug Interactions; Half-Life; Humans; Hypertension; Kidney Diseases; Liver Diseases; Male; Middle Aged; Piperazines | 1988 |
Trials
1 trial(s) available for urapidil and digoxin
| Article | Year |
|---|---|
Effect of urapidil on steady-state serum digoxin concentration in healthy subjects.
Topics: Adult; Antihypertensive Agents; Biological Availability; Blood Pressure; Digoxin; Heart Rate; Humans; Male; Piperazines; Random Allocation | 1989 |
Other Studies
4 other study(ies) available for urapidil and digoxin
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |